A new research has stated that identifying men who are at a risk of developing and dying from prostate cancer is now possible with a single blood test for men aged 60.

In the UK 35,000 are diagnosed with prostate cancer every year.

There have been debates about weighing up the benefits of screening against the potential harms and costs of over-diagnosis and over-treatment of healthy men despite screening being used in certain countries.

Now it has been stated that it could be figured out by a single test that who are the men who needed no further checks and who needed close monitoring.

Six previous screening trials involving 387,286 participants were reviewed by Professor Philipp Dahm and colleagues at the University of Florida. It was noted that the diagnosis of prostate cancer at an earlier stage could be aided by routine screening but on deaths and over-treatment no significant impact was found.

Professor Hans Lilja conducted a second test and it was seen that at age 60 a single prostate-specific antigen level test strongly predicted a man's risk of diagnosis and death from prostate cancer.